Drug class
Cytomegalovirus DNA Terminase Complex Inhibitor
Mechanism of action
DNA Terminase Complex Inhibitors [MoA]
General use cases
- CMV disease in adult and pediatric patients 12 years of age and older and weighing at least 40 kg who are kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R-])
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
